Mark Fineman
University of Massachusetts Lowell(US)University of Baltimore(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, Diet and metabolism studies
Most-Cited Works
- → Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes(2005)1,553 cited
- → Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes(2004)1,338 cited
- → Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea(2005)1,175 cited
- → Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study(2012)561 cited
- → Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes(2003)551 cited
- → Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes(2007)446 cited